ArticleNeuropsychopharmacology reports2025
The Organic Arsenic Compound Diphenylarsinic Acid Transfers From the Mother to the Fetus via the Placenta in Mammals.
Article in Neuropsychopharmacology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundIn 2003, contamination of drinking well water with diphenylarsinic acid (DPAA), an organoarsenic compound not naturally found in the environment, was reported in Kamisu City, Ibaraki Prefecture, due to suspected illegal dumping. Residents in the surrounding area, including pregnant women, were exposed to DPAA, leading to health issues primarily affecting the central nervous system. However, the extent of DPAA transfer from pregnant women to their fetuses remains unknown.
methodsThe concentration of DPAA in preserved dried umbilical cords from pregnant women who had consumed DPAA-contaminated well water was measured using liquid chromatography-tandem mass spectrometry. Additionally, pregnant rats (n = 9) were orally administered DPAA (0.25, 0.5, or 1.0 mg/kg/day) for 13 days. Fetuses (five per mother, n = 45) were delivered, and the DPAA concentrations in maternal and fetal blood, as well as in the brain, were measured.
resultsThe DPAA concentration in fetal blood was 30.0%-40.1% of that in maternal blood, regardless of the administered dose. On the other hand, the DPAA concentration in the fetal brain was 8.31%-9.00% of that in the maternal brain, independent of the administered DPAA dose.
conclusionThe analysis of umbilical cords from pregnant women who drank water containing DPAA revealed that DPAA could transfer from the mother to the fetus through the placenta. Additionally, experiments using rodents confirmed that DPAA could also reach the fetal brain through placental transfer, but the transfer rate was low.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.